Sonendo, Inc. (SONX)
Sonendo, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Laguna Hills, CA, US. The stock last traded at $0.97, down 3.11% on the session, giving a market capitalisation of $414,109. On trailing twelve-month figures it carries a trailing P/E of -0.32, a net margin of -50.5%. Its beta of 1.81 implies it has historically moved more than the broad market.
Sonendo, Inc. operates as a commercial-stage medical technology firm, dedicated to innovating, producing, and marketing advanced devices for root canal treatment across the United States and Canada. A flagship offering is GentleWave, an innovative device for addressing tooth decay that meticulously cleans and sanitizes the intricate microscopic passages within teeth without the need for removing any natural tooth structure. The company's product line also features SoundSeal, a specialized material used to construct and seal dental crowns, alongside its proprietary Sonendo-branded liquid solution of EDTA, which assists in the debridement and disinfection processes crucial for root canal systems. Furthermore, Sonendo provides "The Digital Office," a comprehensive practice management software solution designed to foster an integrated digital environment for dental professionals. Established in 2006, the organization was initially known as Dentatek Corporation before officially rebranding to Sonendo, Inc. in March 2011. Its corporate headquarters are situated in Laguna Hills, California.
Sonendo, Inc. is most often compared with the following Healthcare names: